litlas
Log inCreate account

James T. Willerson

Active 1968–2021

187
Papers
55,069
Citations
124
h-index
187
i10-index

Citations

Citations per year for James T. Willerson1964: 1 citations1968: 1 citations1969: 6 citations1970: 4 citations1971: 5 citations1972: 7 citations1973: 10 citations1974: 8 citations1975: 21 citations1976: 28 citations1977: 44 citations1978: 26 citations1979: 21 citations1980: 17 citations1981: 52 citations1982: 36 citations1983: 60 citations1984: 58 citations1985: 55 citations1986: 70 citations1987: 78 citations1988: 81 citations1989: 112 citations1990: 114 citations1991: 126 citations1992: 105 citations1993: 136 citations1994: 103 citations1995: 115 citations1996: 137 citations1997: 153 citations1998: 133 citations1999: 166 citations2000: 152 citations2001: 188 citations2002: 252 citations2003: 286 citations2004: 483 citations2005: 479 citations2006: 441 citations2007: 420 citations2008: 382 citations2009: 454 citations2010: 467 citations2011: 440 citations2012: 393 citations2013: 420 citations2014: 359 citations2015: 351 citations2016: 336 citations2017: 320 citations2018: 314 citations2019: 904 citations2020: 922 citations2021: 782 citations2022: 636 citations2023: 492 citations2024: 639 citations2025: 285 citations2026: 11 citations1965–1967: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,673 citing papers, 32.7% of this breakdownUnited Kingdom: 1,250 citing papers, 7.2% of this breakdownChina: 1,101 citing papers, 6.4% of this breakdownGermany: 915 citing papers, 5.3% of this breakdownItaly: 886 citing papers, 5.1% of this breakdownCanada: 738 citing papers, 4.3% of this breakdownNetherlands: 645 citing papers, 3.7% of this breakdownJapan: 508 citing papers, 2.9% of this breakdownFrance: 440 citing papers, 2.5% of this breakdownAustralia: 439 citing papers, 2.5% of this breakdownSpain: 354 citing papers, 2% of this breakdownSwitzerland: 293 citing papers, 1.7% of this breakdown
0%32.7%Other 23.7%

Institutions

Fields

  • Medicine69.5%
  • Biochemistry, Genetics and Molecular Biology17.2%
  • Immunology and Microbiology4.5%
  • Neuroscience2.5%
  • Engineering1.4%
  • Materials Science1%
  • Other3.9%

Topics

  • Lipoproteins and Cardiovascular Health3.7%
  • Adipokines, Inflammation, and Metabolic Diseases3.4%
  • Cardiac Imaging and Diagnostics3.3%
  • Coronary Interventions and Diagnostics2.5%
  • Acute Myocardial Infarction Research2.5%
  • Tissue Engineering and Regenerative Medicine2.5%
  • Other82.1%

Coauthors

All papers

Open in search
  1. Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

    Authors: Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, Jacques Genest, Antonio M. Gotto, John J.P. Kastelein, Wolfgang Köenig, Peter Libby, Alberto Lorenzatti, Jean MacFadyen, Børge G. Nordestgaard, James Shepherd, James T. Willerson, Robert J. Glynn - New England Journal of Medicine 2008 cited by 6,637

  2. Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure

    Authors: Eugene S. Chung, Milton Packer, Kim Hung Lo, Adedigbo A. Fasanmade, James T. Willerson - Circulation 2003 cited by 1,635

  3. Inflammation as a Cardiovascular Risk Factor

    Authors: James T. Willerson, Paul M. Ridker - Circulation 2004 cited by 1,291

  4. Circadian Variation in the Frequency of Onset of Acute Myocardial Infarction

    Authors: James E. Muller, Peter H. Stone, Zoltan G. Turi, John D. Rutherford, Charles A. Czeisler, Corette B. Parker, W. Kenneth Poole, Eugene R. Passamani, Robert Roberts, Thomas Robertson, Burton E. Sobel, James T. Willerson, Eugene Braunwald, the MILIS Study Group* - New England Journal of Medicine 1985 cited by 1,875

  5. Hippo pathway deficiency reverses systolic heart failure after infarction

    Authors: John P. Leach, Todd R. Heallen, Min Zhang, Mahdis Rahmani, Yuka Morikawa, Matthew C. Hill, Ana Segura, James T. Willerson, James F. Martin - Nature 2017 cited by 424

  6. From Vulnerable Plaque to Vulnerable Patient

    Authors: Morteza Naghavi, Peter Libby, Erling Falk, S. Ward Casscells, Silvio Litovsky, John A. Rumberger, Juan J. Badimón, Christodoulos Stefanadis, Pedro Moreno, Gerard Pasterkamp, Zahi A. Fayad, Peter H. Stone, Sergio Waxman, Paolo Raggi, Mohammad Madjid, Alireza Zarrabi, Allen Burke, Chun Yuan, Peter J. Fitzgerald, David S. Siscovick, Chris L. de Korte, Masanori Aikawa, Juhani Airaksinen, Gerd Assmann, Christoph R. Becker, James H. Chesebro, Andrew Farb, Zorina S. Galis, Chris Jackson, Ik‐Kyung Jang, Wolfgang Köenig, Robert A. Lodder, Keith L. March, Jasenka Demirovic, Mohamad Navab, Silvia G. Priori, Mark D. Rekhter, Raymond D. Bahr, Scott M. Grundy, Roxana Mehran, Antonio Colombo, Eric Boerwinkle, Christie M. Ballantyne, William Insull, Robert S. Schwartz, Robert A. Vogel, Patrick W. Serruys, Göran K. Hansson, David P. Faxon, Sanjay Kaul, Helmut Drexler, Philip Greenland, James E. Muller, Renu Virmani, Paul M. Ridker, Douglas P. Zipes, Prediman K. Shah, James T. Willerson - Circulation 2003 cited by 2,671

  7. Gene therapy knockdown of Hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction

    Authors: Shijie Liu, Ke Li, Leonardo Wagner Florencio, Li Tang, Todd R. Heallen, John P. Leach, Yidan Wang, Francisco Grisanti, James T. Willerson, Emerson C. Perin, Sui Zhang, James F. Martin - Science Translational Medicine 2021 cited by 138

  8. Hippo signaling impedes adult heart regeneration

    Authors: Todd R. Heallen, Yuka Morikawa, John P. Leach, Ge Tao, James T. Willerson, Randy L. Johnson, James F. Martin - Development 2013 cited by 456

  9. A Phase II study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT‐HF trial

    Authors: Roberto Bolli, Raul D. Mitrani, Joshua M. Hare, Carl J. Pepine, Emerson C. Perin, James T. Willerson, Jay H. Traverse, Timothy D. Henry, Phillip C. Yang, Michael P. Murphy, Keith L. March, Ivonne Hernandez Schulman, Sohail Ikram, David P. Lee, Connor O’Brien, João A.C. Lima, Mohammad R. Ostovaneh, Bharath Ambale‐Venkatesh, Gregory D. Lewis, Aisha Khan, Ketty Bacallao, Krystalenia Valasaki, Bangon Longsomboon, Adrian P. Gee, Sara Richman, Doris A. Taylor, Dejian Lai, Shelly L. Sayre, Judy Bettencourt, Rachel W. Vojvodic, Michelle Cohen, Lara M. Simpson, David Aguilar, Cătălin Loghin, Lem Moyé, Ray F. Ebert, Barry R. Davis, Robert D. Simari - European Journal of Heart Failure 2021 cited by 166

  10. Mutations in Smooth Muscle Alpha-Actin (ACTA2) Cause Coronary Artery Disease, Stroke, and Moyamoya Disease, Along with Thoracic Aortic Disease

    Authors: Dong-Chuan Guo, Christina L. Papke, Van Tran‐Fadulu, Ellen S. Regalado, Nili Avidan, Ralph J. Johnson, Dong Kim, Hariyadarshi Pannu, Marcia Willing, Elizabeth Sparks, Reed E. Pyeritz, Michael Singh, Ronald L. Dalman, James C. Grotta, Ali J. Marian, Eric Boerwinkle, Lorraine Frazier, Scott A. LeMaire, Joseph S. Coselli, Anthony L. Estrera, Hazim J. Safi, Sudha Veeraraghavan, Donna M. Muzny, David A. Wheeler, James T. Willerson, Robert Yu, Sanjay Shete, Steven E. Scherer, C.S. Raman, L. Maximilian Buja, Dianna M. Milewicz - The American Journal of Human Genetics 2009 cited by 574

  11. Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells

    Authors: Vincenzo Pasceri, James T. Willerson, Edward T.H. Yeh - Circulation 2000 cited by 1,940

  12. Actin cytoskeletal remodeling with protrusion formation is essential for heart regeneration in Hippo-deficient mice

    Authors: Yuka Morikawa, Min Zhang, Todd R. Heallen, John P. Leach, Ge Tao, Yang Xiao, Yan Bai, Wei Li, James T. Willerson, James F. Martin - Science Signaling 2015 cited by 226

  13. pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque

    Authors: Morteza Naghavi, Reji John, Sameh Naguib, Mir S. Siadaty, Roxana Grasu, K.C Kurian, W B Van Winkle, Babs R. Soller, Silvio Litovsky, Mohammad Madjid, James T. Willerson, Ward Casscells - Atherosclerosis 2002 cited by 207

  14. Leukocyte count and coronary heart disease

    Authors: Mohammad Madjid, Imran Awan, James T. Willerson, S. Ward Casscells - Journal of the American College of Cardiology 2004 cited by 658

  15. Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy

    Authors: Sirisha Cheedipudi, Scot J. Matkovich, Cristian Coarfa, Xin Hu, Matthew J. Robertson, Mary Sweet, Matthew R.G. Taylor, Luisa Mestroni, Joseph C. Cleveland, James T. Willerson, Priyatansh Gurha, Ali J. Marian - Circulation Research 2019 cited by 135

  16. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

    Authors: Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, Jacques Genest, Antonio M. Gotto, John J.P. Kastelein, Wolfgang Köenig, Peter Libby, Alberto Lorenzatti, Jean MacFadyen, Børge G. Nordestgaard, James Shepherd, James T. Willerson, Robert J. Glynn - The Lancet 2009 cited by 1,020

  17. Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells

    Authors: Paolo Calabrò, James T. Willerson, Edward T.H. Yeh - Circulation 2003 cited by 579

  18. Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failure

    Authors: Emerson C. Perin, James T. Willerson, Carl J. Pepine, Timothy D. Henry, Stephen G. Ellis, David Zhao, Guilherme V. Silva, Dejian Lai, James D. Thomas, Marvin W. Kronenberg, A. Daniel Martin, R. David Anderson, Jay H. Traverse, Marc S. Penn, Saif Anwaruddin, Antonis K. Hatzopoulos, Adrian P. Gee, Doris A. Taylor, Christopher R. Cogle, Deirdre Smith, Lynette Westbrook, James Chen, Eileen Handberg, Rachel Olson, Carrie Geither, Sherry Bowman, Judy Francescon, Sarah Baraniuk, Linda B. Piller, Lara M. Simpson, Cătălin Loghin, David Aguilar, Sara Richman, Claudia Zierold, Judy Bettencourt, Shelly L. Sayre, Rachel W. Vojvodic, Sonia I. Skarlatos, David J. Gordon, Ray F. Ebert, Minjung Kwak, Lemuel A. Moyé, Robert D. Simari - JAMA 2012 cited by 455

  19. The VIVA Trial

    Authors: Timothy D. Henry, Brian H. Annex, George R. McKendall, Michael Azrin, John J. López, Frank J. Giordano, PK Shah, James T. Willerson, Raymond L. Benza, Daniel S. Berman, C. Michael Gibson, Alex Bajamonde, Amy Chen Rundle, Jennifer Fine, Edward R. McCluskey - Circulation 2003 cited by 1,023

  20. A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

    Authors: Robert J. Glynn, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, Jacques Genest, Antonio M. Gotto, John J.P. Kastelein, Wolfgang Köenig, Peter Libby, Alberto Lorenzatti, Jean MacFadyen, Børge G. Nordestgaard, James Shepherd, James T. Willerson, Paul M. Ridker - New England Journal of Medicine 2009 cited by 751

  21. Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction

    Authors: Jay H. Traverse, Timothy D. Henry, Carl J. Pepine, James T. Willerson, David Zhao, Stephen G. Ellis, John R. Forder, R. David Anderson, Antonis K. Hatzopoulos, Marc S. Penn, Emerson C. Perin, Jeffrey Chambers, Kenneth W. Baran, Ganesh Raveendran, Charles Lambert, Amir Lerman, Daniel I. Simon, Douglas E. Vaughan, Dejian Lai, Adrian P. Gee, Doris A. Taylor, Christopher R. Cogle, James D. Thomas, Rachel Olson, Sherry Bowman, Judy Francescon, Carrie Geither, Eileen Handberg, Casey Kappenman, Lynette Westbrook, Linda B. Piller, Lara M. Simpson, Sarah Baraniuk, Cătălin Loghin, David Aguilar, Sara Richman, Claudia Zierold, Daniel B. Spoon, Judy Bettencourt, Shelly L. Sayre, Rachel W. Vojvodic, Sonia I. Skarlatos, David J. Gordon, Ray F. Ebert, Minjung Kwak, Lemuel A. Moyé, Robert D. Simari - JAMA 2012 cited by 388

  22. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial

    Authors: Emerson C. Perin, Ricardo Sanz‐Ruiz, Pedro L. Sánchez, José M. Lasso, Rosa Pérez-Cano, J.C. Alonso Farto, Esther Pérez David, María Eugenia Fernández‐Santos, Patrick W. Serruys, Henrick J. Duckers, Jens Kastrup, Steven A. J. Chamuleau, Yi Zheng, Guilherme V. Silva, James T. Willerson, Francisco Fernández‐Avilés - American Heart Journal 2014 cited by 282

  23. The Hippo Pathway Is Activated and Is a Causal Mechanism for Adipogenesis in Arrhythmogenic Cardiomyopathy

    Authors: Suet Nee Chen, Priyatansh Gurha, Raffaella Lombardi, Alessandra Ruggiero, James T. Willerson, Ali J. Marian - Circulation Research 2013 cited by 271

  24. Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure

    Authors: Rosalinda Madonna, Linda W. van Laake, Sean M. Davidson, Felix B. Engel, Derek J. Hausenloy, Sandrine Lecour, Jonathan Leor, Cinzia Perrino, Rainer Schulz, Kirsti Ytrehus, Ulf Landmesser, Christine L. Mummery, Stefan Janssens, James T. Willerson, Thomas Eschenhagen, Péter Ferdinandy, Joost P. G. Sluijter - European Heart Journal 2016 cited by 242